Delivery Order SPE2DB22D3301-SPE2DB24FY1VV

Award Date 3/4/24
Potential Completion Date 3/25/24
Potential Value $12K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,960.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a potential value of $12,345.34 and a completion date of March 15, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $24,690.70 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4563802200 - VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a completion date of March 20, 2024 and was awarded on February 28, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, that serves as...
The Defense Logistics Agency (DLA) awarded a $12,345.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a ceiling value of $12,345.34 and a performance period through April 4, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as...
The U.S. Department of Defense, Medical Supply Chain awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The contract, valued at $49,381.36, is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The $12,960.30 contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has received numerous prior awards from DLA Troop Support Medical to supply pharmaceuticals, medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $24,690.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. This order is part of Amerisourcebergen's indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. The delivery order has a completion date of January 12, 2024. Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $12,345.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product, with a completion date of March 4, 2024. This award is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a ceiling value of $12,960.30 and a performance period through April 29, 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA to deliver a comprehensive range of pharmaceutical products and...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY1VV
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, to provide VYNDAMAX 61 MG CAPSULE UD 30S. The contract has a completion date of March 25, 2024 and a potential value of $12,345.34. This delivery order is part of a larger indefinite delivery contract awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense, through DLA Troop Support Medical.

Generated 6/3/24, 9:03 AM